Cardiac Biomarker ST2 Identifies Chronic Heart Failure Patients To Benefit …
PharmaLive (press release) (subscription) “ST2 is unlike any biomarker in heart failure because of its enduring prognostic strength, but now, as evidenced by the encouraging results from this study, ST2 holds the final link in potentially improving outcomes for heart failure patients through … |
Anemia drugs does not improve health of anemic heart failure patients – EurekAlert (press release)
![]() Health Newstrack |
Anemia drugs does not improve health of anemic heart failure patients
EurekAlert (press release) Researchers from Sahlgrenska Academy, University of Gothenburg, Sweden, have found that a commonly used drug to treat anemia in heart failure patients does not improve patients’ health, nor does it reduce their risk of death from heart failure. Results … ACC: Anemia Drug No Help in Heart FailureMedPage Today Anemia treatment not beneficial in heart failureFamily Practice News Digital Network ACC: Darbepoetin Alfa Doesn’t Up Outcome in Heart FailureDoctors Lounge Forbes all 5 news articles » |
Erectile dysfunction drug fails for diastolic heart failure patients – Science Codex
![]() RedOrbit |
Erectile dysfunction drug fails for diastolic heart failure patients
Science Codex SAN FRANCISCO (March 11, 2013) — Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology … ASTRONAUT trial finds no beneficial effects of aliskiren in recently …News-Medical.net Viagra No Help in Heart FailureMedPage Today Sildenafil falls short for heart failure with preserved ejection fractionFamily Practice News Digital Network RedOrbit –French Tribune –Doctors Lounge all 17 news articles » |
No benefit found from BP drug in treatment of recently hospitalized heart … – Medical Xpress
No benefit found from BP drug in treatment of recently hospitalized heart …
Medical Xpress Despite high hopes that a blood pressure-lowering medication called aliskiren would help people following hospitalization for heart failure, no beneficial effects were found, according to research presented today at the American College of Cardiology’s … Combination therapy for heart failure does not reduce risk of CV death or …EurekAlert (press release) Direct renin inhibitor aliskiren flops as add-on therapy in systolic HF: ASTRONAUTTheHeart.Org ASTRONAUT Study: No Significant Post-Discharge Mortality Benefit Seen with …Monthly Prescribing Reference |
Screenings, targeted care reduce heart failure in at-risk patients – Medical Xpress
Screenings, targeted care reduce heart failure in at-risk patientsMedical XpressThe five-year STOP-HF study enrolled asymptomatic patients over 40 years of age with risk factors for heart failure and randomized them into an intervention and a control g…
Erectile dysfunction drug fails for diastolic heart failure patients – EurekAlert (press release)
![]() Zee News |
Erectile dysfunction drug fails for diastolic heart failure patients
EurekAlert (press release) SAN FRANCISCO (March 11, 2013) — Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology … Viagra `not helpful for heart failure patients`Zee News Viagra is no help against heart failure: studyTimes LIVE Viagra, Aliskiren Not Helpful for Heart Failure After All: StudiesHealth.com Medical Xpress –RedOrbit –MedPage Today all 12 news articles » |
CMV Prevention Drug Fast-Tracked by FDA – Monthly Prescribing Reference
CMV Prevention Drug Fast-Tracked by FDA
Monthly Prescribing Reference Phase 2 clinical development of CMX001, for the prevention of CMV infection in adult hematopoietic stem cell transplant (HSCT) recipients, has been completed. Chimeric is planning on initiating SUPPRESS, a Phase 3 study of CMX001 for the prevention of … Chimerix antiviral lands on FDA’s fast trackWRAL Tech Wire Chimerix receives FDA Fast Track designation for CMX001 to prevent CMV …News-Medical.net |
Screenings, targeted care reduce heart failure in at-risk patients – EurekAlert (press release)
Screenings, targeted care reduce heart failure in at-risk patients
EurekAlert (press release) SAN FRANCISCO (March 11, 2013) — For at-risk patients, a simple screening and management program can be effective in preventing heart failure, according to research presented today at the American College of Cardiology’s 62nd Annual Scientific … |
Digoxin reduces hospital admissions in older patients with chronic heart failure – EurekAlert (press release)
Digoxin reduces hospital admissions in older patients with chronic heart failure
EurekAlert (press release) SAN FRANCISCO (March 11, 2013) —Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction (HFrEF), according to research presented … Simple test can reduce heart failure riskIrish Health Blood Test Plus Targeted Care May Stop Heart Failure Before It StartsHealth.com ACC: Digoxin Cuts 30-Day Admission for Heart FailureDoctors Lounge |
Early treatment for depression after liver transplantation linked to better … – Healio
Early treatment for depression after liver transplantation linked to better …HealioResearchers evaluated 167 patients who underwent liver transplantation (LT) because of alcohol-related liver disease between 1998 and 2003. Symptoms of depression were…